BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,880 | -85.8% | 4,000 | -82.2% | 0.00% | -85.7% |
| Q2 2023 | $1,416,944 | +40.5% | 22,420 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $1,008,676 | -75.5% | 22,420 | -76.1% | 0.01% | -76.0% |
| Q4 2022 | $4,118,140 | -93.3% | 94,000 | -92.2% | 0.02% | -92.5% |
| Q2 2022 | $61,217,000 | -29.4% | 1,211,987 | -10.7% | 0.33% | -20.1% |
| Q1 2022 | $86,684,000 | -0.3% | 1,356,987 | +67.2% | 0.42% | -3.7% |
| Q4 2021 | $86,946,000 | -10.5% | 811,747 | -14.0% | 0.43% | -4.2% |
| Q3 2021 | $97,094,000 | -1.9% | 944,403 | -16.1% | 0.45% | +12.1% |
| Q2 2021 | $98,955,000 | +46.5% | 1,125,000 | +61.9% | 0.40% | +20.2% |
| Q1 2021 | $67,555,000 | – | 694,791 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |